Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tempus AI, Inc. (TEM : NSDQ)

• Company Description    Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. Number of Employees: 3,800

• Price / Volume Information    Yesterday's Closing Price: $53.25 Daily Weekly Monthly 20 Day Moving Average: 5,800,455 shares Shares Outstanding: 177.91 (millions) Market Capitalization: $9,473.56 (millions) Beta: 5.29 52 Week High: $104.32 52 Week Low: $36.22 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.98% -10.20% 12 Week -30.54% -30.62% Year To Date -9.82% -10.26%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 600 WEST CHICAGO AVENUE SUITE 510 - CHICAGO,IL 60654 USA ph: 800-976-5448 fax: - investorrelations@tempus.com http://www.tempus.com

• General Corporate Information    Officers Eric Lefkofsky - Chief Executive Officer; Founder and Chairman James Rogers - Chief Financial Officer Ryan Bartolucci - Chief Accounting Officer Peter J. Barris - Director Eric D. Belcher - Director Peer Information Tempus AI, Inc. (HLIS) Tempus AI, Inc. (AZTA) Tempus AI, Inc. (APYI) Tempus AI, Inc. (RNVA) Tempus AI, Inc. (HMSY) Tempus AI, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88023B103 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/05/26 Share - Related Items Shares Outstanding: 177.91 Most Recent Split Date: (:1) Beta: 5.29 Market Capitalization: $9,473.56 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.44 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.29 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 43.93% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 19.28 Price/Cash Flow: - Price / Sales: 7.45 EPS Growth vs. Year Ago Period: 12.12% vs. Previous Quarter: 6.45% Sales Growth vs. Year Ago Period: 82.98% vs. Previous Quarter: 9.88% ROE 12/31/25 - -53.30 09/30/25 - -73.21 06/30/25 - -122.86 ROA 12/31/25 - -11.28 09/30/25 - -13.78 06/30/25 - -18.09 Current Ratio 12/31/25 - 3.13 09/30/25 - 3.28 06/30/25 - 1.54 Quick Ratio 12/31/25 - 3.00 09/30/25 - 3.12 06/30/25 - 1.43 Operating Margin 12/31/25 - -17.13 09/30/25 - -19.87 06/30/25 - -24.06 Net Margin 12/31/25 - -19.27 09/30/25 - -18.45 06/30/25 - -20.98 Pre-Tax Margin 12/31/25 - -22.89 09/30/25 - -22.12 06/30/25 - -24.93 Book Value 12/31/25 - 2.76 09/30/25 - 2.85 06/30/25 - 1.78 Inventory Turnover 12/31/25 - 9.26 09/30/25 - 8.84 06/30/25 - 8.66 Debt-to-Equity 12/31/25 - 2.52 09/30/25 - 2.45 06/30/25 - 2.58 Debt-to-Capital 12/31/25 - 71.61 09/30/25 - 71.04 06/30/25 - 72.05

Powered by Zacks Investment Research ©